Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Non-Current Assets (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Non-Current Assets for 4 consecutive years, with $11227.0 as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 70.91% to $11227.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $85951.0 through Dec 2025, down 56.01% year-over-year, with the annual reading at $11227.0 for FY2025, 70.91% down from the prior year.
  • Non-Current Assets hit $11227.0 in Q4 2025 for Coya Therapeutics, down from $18068.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.2 million in Q4 2022 to a low of $11227.0 in Q4 2025.
  • Historically, Non-Current Assets has averaged $138214.2 across 4 years, with a median of $52269.0 in 2024.
  • Biggest five-year swings in Non-Current Assets: crashed 94.55% in 2023 and later crashed 31.64% in 2024.
  • Year by year, Non-Current Assets stood at $1.2 million in 2022, then plummeted by 94.55% to $65949.0 in 2023, then plummeted by 41.49% to $38588.0 in 2024, then tumbled by 70.91% to $11227.0 in 2025.
  • Business Quant data shows Non-Current Assets for COYA at $11227.0 in Q4 2025, $18068.0 in Q3 2025, and $24908.0 in Q2 2025.